Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP379625.RAXpJmJECZm4g8U2fUriHnizp8ko8fU3CLI5mX44XFZh8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP379625.RAXpJmJECZm4g8U2fUriHnizp8ko8fU3CLI5mX44XFZh8130_assertion type Assertion NP379625.RAXpJmJECZm4g8U2fUriHnizp8ko8fU3CLI5mX44XFZh8130_head.
- NP379625.RAXpJmJECZm4g8U2fUriHnizp8ko8fU3CLI5mX44XFZh8130_assertion description "[The high concordance between HER2 results for PGCs and their LNMs indicates that assessment of HER2 status in the primary cancer alone is a reliable basis for deciding treatment with anti-HER2 agents in patients with LNMs from gastric adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379625.RAXpJmJECZm4g8U2fUriHnizp8ko8fU3CLI5mX44XFZh8130_provenance.
- NP379625.RAXpJmJECZm4g8U2fUriHnizp8ko8fU3CLI5mX44XFZh8130_assertion evidence source_evidence_literature NP379625.RAXpJmJECZm4g8U2fUriHnizp8ko8fU3CLI5mX44XFZh8130_provenance.
- NP379625.RAXpJmJECZm4g8U2fUriHnizp8ko8fU3CLI5mX44XFZh8130_assertion SIO_000772 24261710 NP379625.RAXpJmJECZm4g8U2fUriHnizp8ko8fU3CLI5mX44XFZh8130_provenance.
- NP379625.RAXpJmJECZm4g8U2fUriHnizp8ko8fU3CLI5mX44XFZh8130_assertion wasDerivedFrom befree-20150227 NP379625.RAXpJmJECZm4g8U2fUriHnizp8ko8fU3CLI5mX44XFZh8130_provenance.
- NP379625.RAXpJmJECZm4g8U2fUriHnizp8ko8fU3CLI5mX44XFZh8130_assertion wasGeneratedBy ECO_0000203 NP379625.RAXpJmJECZm4g8U2fUriHnizp8ko8fU3CLI5mX44XFZh8130_provenance.